Event eITT Keyvisual

External Innovation Think Tank (eITT) Exhibition 2021

Application Flyer 2021 (pdf)

Annual External Exhibition of Innovation Think Tank Siemens Healthineers (eITT 2021)

Call for participation for interdisciplinary participants from Universities, Start-ups, and Industries

eitt flyer
Submit your project now until the 1st of May 2021 to get the chance to present your projects to experts from various industries and universities, learn from other best practices and get the chance to win an award.


Innovation Think Tank (ITT), a part of the Chief Technology Office of Siemens Healthineers, is organizing its annual external exhibition (eITT 2021) on 28th July 2021, at its headquarters in Erlangen, Germany. The event focuses on open innovation, cocreation and disruptive innovations in the area of healthcare. Best practices at our various ITT locations and collaborations along with applicants from other institutions, start-ups and industries will be presented.

Annually, nearly 200 Innovation Think Tank Fellowships* are awarded to participants from various universities and research institutions giving them the opportunity to work on interdisciplinary projects at ITT locations worldwide. Open innovation projects worked on by the ITT participants and external applicants can be nominated for eITT 2021. In the past years, up to 40 project teams took part in the annual exhibition. The top five teams will be recognized based on an evaluation by the guest jury including senior management of Siemens Healthineers.

*Applications can be submitted throughout the year.

  • Disruptive innovation projects
  • Open innovation, co-creation platforms and best practices
  • Healthcare system of the future
  • Hospital of the future
  • Precision medicine
  • Patient experience
  • Lab diagnostics of the future
  • Knowledge management
  • Operation room of the future
  • 3D printing
  • Machine learning
  • Innovations in consumer electronics
  • How to improve quality of human life
  • Next generation IT (Apps for medical devices)
  • Green hospitals
  • Scientific improvement e.g. cardio and neuro imaging
  • Medical devices of the future
  • Ideas demonstrating cost reduction in medical devices and healthcare systems
  • Disruptive innovation processes and methodologies
  • System simulators
  • People management best practices
  • Industry 4.0 applications in healthcare etc.
  • mail icon
    Send your proposal for eITT 2021 as PDF to innovationthinktank.team@siemens-healthineers.com

    The proposal should include: Challenge / Goal of the project, Current state of art, how the challenge is addressed today, proposed solution, design or visualization (if created), description of any prototype or model or simulation (if exist), benefits of the current solutions.

    No page limit and no restriction of formatting. 

    Please also note that this is a public event so clarify any IP issues with your organization.

    calendar icon
    • Application deadline for Innovation Think Thank Fellowships for eITT 2021: 1 May 2021
    • Application deadline for direct applicants for project presentation at eITT 2021: 15 May 2021
    • Finalist announcement: 20 May 2021
    • eITT 2020 Event: 28th July 2021

    Apply now and get the chance to present your projects to experts from various industries and universities, learn from other best practices and get the chance to win an award.

    Applications for the Innovation Think Tank Fellowships could be submitted throughout the year via Siemens Healthineers Job portal. Please look for „Innovation Think Tank“ keyword in the Siemens Healthineers job search to apply for the appropriate positions or send an email to innovationthinktank.team@siemens-healthineers.com

    https://www.healthcare.siemens.com/careers/innovation-think-tank

    External Innovation Think Tank (eITT) Exhibition 2020

    We as the Innovation Think Tank - part of the Chief Technology Office of Siemens Healthineers – are happy to welcome you to our annual external Innovation Think Tank (eITT) Exhibition 2020. The event focuses on open innovation and co-creation in the area of healthcare by bringing together key stakeholders such as hospitals, research institutions, universities, start-ups and VCs.

    The focus of this year's exhibition is to show the complete pathways for the most prominent diseases (e.g. coronary artery disease, cancer, diabetes etc.), the impact of COVID-19 on them and the possible solutions to solve these challenges. They are in the areas of digitalization, automation, new diagnostic and treatment methods, clinical innovation and process improvements in the healthcare system.

    Due to the current COVID-19 pandemic and digitalization being one of the key strategies for Siemens Healthineers, we have modified the format of our ITT exhibition 2020 to a virtual recorded event which includes

    • Recorded speeches from experts and management representatives from Siemens Healthineers and ITT key collaboration partners showing what we did together in the last years, what our plans for the next year are and how interdisciplinary Innovation Think Tank methodology has been helping in addressing the complex challenges in healthcare (bringing experts, disciplines, locations and healthcare system stakeholders together).
    • Virtual tour of the ITT Office and lab giving an insight into our infrastructure, methodology and processes.
    • Projects in the following areas by ITT Fellows and members from ITT locations and collaborations worldwide
      • Facts and figures about 12 diseases, chosen based on top economic burden, social impact and mortality
      • How disease pathways get influenced by the challenges from COVID-19
      • Possible solutions to address those challenges in various disease pathways

    This format allows you to have a look at the speeches of your choice at any time and disease content in the areas of your interest at any time as well as to share feedback with us.

    Recorded Speeches from Experts and Management Representatives from Siemens Healthineers and ITT Key Collaboration Partners

    Dr. Peter Schardt, Chief Technology Officer, Siemens Healthineers

    Dr. Fatih Gül, Chief Operating Officer, Fakeeh University Hospital Dubai

    Dr. Sonja Förster, Post Doctoral Researcher, ETH Zurich

    Prof. James Moore JR, Bagrit Chair in Medical Device Design, Imperial College London

    Prof. Michael Fisher, Director of Product Development, GCMI

    Prof. Andrew Menard, Chief Administrative Officer, Radiology Johns Hopkins

    Dr. Charles Harr, Chief Medical Officer – Cardiovascular Thoracic Surgeon, WakeMed Health and Hospital

    Enis Sonemel, Managing Director of Turkey, Siemens Healthineers

    • Dr. Peter Schardt, Chief Technology Officer, Siemens Healthineers
    • Dr. Fatih Gül, Chief Operating Officer, Fakeeh University Hospital Dubai
    • Dr. Sonja Förster, Post Doctoral Researcher, ETH Zurich
    • Prof. James Moore JR, Bagrit Chair in Medical Device Design, Imperial College London
    • Ole Per Måløy, Managing Director Middle East and Southern & Eastern Africa, Siemens Healthineers & Dr. Mohaymen Abdelghany, CEO Al Zahra Hospital
    • Prof. Rafael Song, Associate Professor of Mechanical and Biomedical Engineering, New York University Abu Dhabi
    • Dr. Osama Abdullah, MRI Physicist, New York University Abu Dhabi
    • Andre Heinz, Head of Human Resources, Siemens Healthineers
    • Hannah Moon, Global Internship Advisor, Georgia Institute of Technology
    • Dr. Kong Jun, General Manager of SSME, Siemens Healthineers
    • Renato Buselli, Head of Latin America, Siemens Healthineers
    • Prof. Giovanni Cerri, President of the Innovation Board of HCFMUSP
    • Prof. Ata Akin, Dean of Engineering, Acibadem University Istanbul
    • Sevket On, Managing Director and President, Siemens Healthineers Canada
    • Dr. Stefan Henkel, Head of IT, Siemens Healthineers
    • Neşet Hikmet, Ph.D., Academic Director & Benjamin Schooley, Ph.D., Innovation Director & Dilek Akgun, RTTP, Operations Director, University of South Carolina ITT Lab
    • Prof. Michael Fisher, Director of Product Development, GCMI
    • Prof. Andrew Menard, Chief Administrative Officer, Radiology Johns Hopkins
    • Dr. Charles Harr, Chief Medical Officer - Cardiovascular Thoracic Surgeon, WakeMed Health and Hospital
    • Enis Sonemel, Managing Director of Turkey, Siemens Healthineers
    • Prof. Burak Acar, Professor of Electrical and Electronics Engineering & Prof. Suzan Uskudarli, Computer Engineering Department, Boğaziçi University Istanbul
    • Ufuk Eren, Chief Executive Officer, Volitan Global
    • Prof. David Franklin, Professor for Neuromuscular Diagnostics, Technical University Munich
    • Prof. Michael Friebe, HealthTec Innovation Lab, Medical Faculty, Otto-von-Guericke-University Magdeburg
    • Steffen März, Chief Financial Officer and Managing Director & Dr. Roopika Menon, Head of Customer Management & Dr. Stefan Foser, Chief Technical Officer, NEO NewOncology
    • Prof. Dr. Georg Michelson, Senior Physician, Ophthalmology
    • Daniel Rinck, Innovation Manager and Head of Innovation Think Tank at Magnetic Resonance Imaging, Siemens Healthineers
    • Prof. Debasish Mishra, School of Bio-Sciences and Technology at Vellore Institute of Technology (VIT)
    • Prof. Sandeep Singh, Department of Cardiology, Executive Director, School of International Biodesign, All India Institute of Medical Sciences, New Delhi
    • Martin Hecht, Head of PLM at Mechatronic Products, Siemens Healthineers
    • Gassan Azem, Head of Computed Tomography Performance Product Line, Siemens Healthineers

    Virtual ITT Office and Lab Tour

    Disease Pathways influenced by COVID-19

    We would like to cordially thank all of you for your invaluable contributions for the annual external Innovation Think Tank Exhibition 2020:

    • Dr. Peter Schardt, Chief Technology Officer, Siemens Healthineers,
    • Dr. Fatih Gül, Chief Operating Officer, Fakeeh University Hospital Dubai
    • Dr. Sonja Förster, Post-Doctoral Researcher, ETH Zurich
    • Prof. James Moore JR, Bagrit Chair in Medical Device Design, Imperial College London
    • Ole Per Måløy, Managing Director Middle East and Southern & Eastern Africa, Siemens Healthineers
    • Prof. Rafael Song, Associate Professor of Mechanical and Biomedical Engineering, New York University Abu Dhabi
    • Dr. Osama Abdullah, MRI Physicist, New York University Abu Dhabi
    • Andre Heinz, Head of Human Resources, Siemens Healthineers
    • Hannah Moon, Global Internship Advisor, Georgia Institute of Technology
    • Dr. Kong Jun, General Manager of SSME, Siemens Healthineers
    • Renato Buselli, Head of Latin America, Siemens Healthineers
    • Prof. Giovanni Cerri, President of the Innovation Board of HCFMUSP
    • Prof. Ata Akin, Dean of Engineering, Acibadem University Istanbul
    • Sevket On, Managing Director and President, Siemens Healthineers Canada
    • Dr. Stefan Henkel, Head of IT, Siemens Healthineers
    • Prof. Dr. Jochen Hampe, Head of Gastroenterology and Hepatology at Carl Gustav Carus Dresden, Head of EKZF Institute Dresden
    • Neşet Hikmet, Ph.D., Academic Director & Benjamin Schooley, Ph.D., Innovation Director & Dilek Akgun, RTTP, Operations Director, University of South Carolina ITT Lab
    • Prof. Burak Acar, Professor of Electrical and Electronics Engineering & Prof. Suzan Uskudarli, Computer Engineering Department, Boğaziçi University Istanbul
    • Ufuk Eren, Chief Executive Officer, Volitan Global
    • Prof. David Franklin, Professor for Neuromuscular Diagnostics, Technical University Munich
    • Prof. Michael Friebe, HealthTec Innovation Lab, Medical Faculty, Otto-von-Guericke-University Magdeburg
    • Steffen März, Chief Financial Officer and Managing Director & Dr. Roopika Menon, Head of Customer Management & Dr. Stefan Foser, Chief Technical Officer, NEO NewOncology
    • Daniel Rinck, Innovation Manager and Head of Innovation Think Tank at Magnetic Resonance Imaging, Siemens Healthineers
    • Prof. Dr. Georg Michelson, Senior Physician, Ophthalmology
    • Prof. Debasish Mishra, School of Bio-Sciences and Technology at Vellore Institute of Technology (VIT)
    • Prof. Sandeep Singh, Department of Cardiology, Executive Director, School of International Biodesign, All India Institute of Medical Sciences, New Delhi
    • Martin Hecht, Head of PLM at Mechatronic Products, Siemens Healthineers
    • Gassan Azem, Head of Computed Tomography Performance Product Line, Siemens Healthineers
    • Dr. Mohammad Ali, Senior Resident Doctor at Department of Radiation Oncology, King George Medical University, India
    • Dr. Pooja Radhakrishna, Product Owner/System Engineer with the AT VSS team, Siemens Healthineers
    • Prof. Dr. İ. Haldun Müderrisoğlu, Dean of the Medical Faculty – Head of the Cardiology Department, Baskent Hospital
    • Assoc. Prof Uğur Abbas Bal, Department of Cardiology, Baskent Hospital
    • Asst. Prof. Emir Karaçağlar, Department of Cardiology, Baskent Hospital
    • Prof. Dr. Ufuk Can, Head of the Neurology Department, Baskent Hospital
    • Dr. Seda Kibaroğlu, Department of Neurology, Baskent Hospital
    • Prof. Dr. Müşerref Şule Akçay, Head of the Pulmonary Diseases Department, Baskent Hospital
    • Prof. Dr. Ayşe Elif Küpeli, Department of Pulmonary Diseases, Baskent Hospital
    • Prof. Dr. Neslihan Başçıl Tütüncü, Head of the Endocrinology and Metabolic Diseases Department, Baskent Hospital
    • Prof. Dr. Özden Altundağ, Head of the Department of Medical Oncology, Baskent Hospital
    • Prof. Dr. Adnan Torgay, Chief Physician of Başkent University Ankara Hospital, Baskent HospitalHanife Altuntaş, Management Secretary, Baskent Hospital
    • Arzu Fırlarer, Coordinator at Baskent ITT, Baskent Hospital
    • Aylin Dedeoğlu, Baskent ITT – Entrepreneurship & Prototyping Lab Expert, Baskent Hospital
    • Dr. Adil Khan Yusuf Zai, Innovation fellow, School of International Biodesign (Stanford India Biodesign), AIIMS & IIT-Delhi
    • Balamurugan S, Innovation Fellow, School of International Biodesign, AIIMS - New Delhi
    • Enis Sonemel, Managing Director of Turkey, Siemens Healthineers

    It begins with unborn children: how can expectant mothers reduce their child’s risk of disease? How can we improve the diagnosis, treatment and the handling of breast cancer, for example? The “Innovation Think Tank” (ITT) has for the first time developed complex treatment plans for twelve diseases which pose the biggest risk to mankind. The core idea: technological innovation. Some treatment plans were presented internationally at the annual external ITT Exhibition on July 11, 2019.
    One in eight women will develop breast cancer in their lifetime. According to the WHO, it is estimated that 627,000 women died from breast cancer in 2018 – that is approximately 15% of all cancer deaths among women. For the patients themselves and their social circle the disease is tragic and traumatic, much the same as many other sometimes fatal diseases. “We want to change that. That's why at ITT we’re analyzing the most difficult points in the treatment paths of the deadliest and most costly diseases over the entire life and disease cycle of humans. This begins in the womb and ends with aftercare,” explains Sultan Haider, founder and head of ITT at Healthineers at this year's Innovation Think Tank exhibition (eITT 2019) in Erlangen.

    Basis for joint research and development
    He addressed the 130 participants from around 40 international organizations: “We are aware of the problems with the prevention, diagnosis, treatment and aftercare of diseases like breast cancer. Action must be taken, and that’s exactly what we are doing: our response is technological innovations which will help patients, doctors and others involved to prevent the disease or to halt its progress. The technology is available! The important thing now is that all of us - technology companies and start-ups, research institutes and universities - work together to make it operational.” The health system is also groaning under the weight of the worst diseases, says Haider, so much of it is also about reducing the financial burden along the whole treatment pathway. Again, new technologies are the key here.

    How do technological innovations help?
    They are designed to save time, and therefore money, improve the patient experience and enable access to important information for the doctors, hospital administration or governmental bodies. Specifically, it is about three fields of technology: digital technologies, such as the Internet of Medical Things (IoMT), the 5G mobile communication standard, artificial intelligence or Blockchain which we are combining in the treatment pathways with automated solutions – focusing here on robotics and sensors – and clinical innovations such as new diagnostic methods, digital pathology or minimally invasive procedures for example.

    Which diseases are being looked at?
    Haider’s ITT team have identified twelve diseases whose global burden – both social and economic – is particularly high:

    Cluster of 12 global diseases

    1. Lung Cancer; 2. Breast Cancer; 3. Leukemia; 4. Chronic Obstructive Pulmonary Disease (COPD); 5. Tuberculosis (TB); 6. Multiple Sclerosis (MS); 7. Alzheimer’s Disease; 8. Parkinson’s Disease; 9. Coronary Artery Disease; 10. Stroke; 11. Diabetes; 12. Traumatic Injuries
     

    Around 150 employees in different ITT teams around the world have already been working for several years to build an enormous and broad database of these diseases. The data comes from, among sources, health organizations and scientific journals. In order to develop the matrix-like, highly complex treatment pathways they followed the life and the progression of the patient with all the different interfaces to their social and medical environment.

    Sultan Haider
    dummy

    Working prototype of a portable ultrasound device for remote diagnosis.
    Each treatment pathway includes predefined stations through which the patient moves. In the case of breast cancer, for example, these are: prenatal, prevention, symptoms, diagnosis, rehabilitation and outpatient care, which includes reintegration into everyday life after inpatient cancer treatment.

    Sultan Haider
    Smart Bra
    • The situation: A patient can sense changes in her breast.
    • Points of difficulty: She does not go to a regular check, perhaps because she is worried about the somewhat uncomfortable situation during the examination or the examination itself.
    • Possible solutions: An app (digital innovation) reminds her to get her breasts examined. She receives a portable ultrasound device (clinical innovation) for remote diagnosis, which instructs the patient on how to screen her breast herself at home. In addition, if the woman has difficulty detecting changes in her breast an intelligent sensor-equipped bra (digital innovation) could also help her.

    The audience are appreciative of ITT's extensive analysis and treatment pathways. Peter Schardt, Chief Technology Officer and responsible for the Technology & Innovation (TI) organization, to which ITT also belongs, is impressed:

    Peter Schardt
    Peter Schardt
    Sultan Haider

    Here you can find an example of a care plan – breast cancer: Download PDF

    For more and detailed information about the disease and projects please feel free to contact us:
    innovationthinktank.team@siemens-healthineers.com

    Innovation Think Tank (ITT) is a part of the Chief Technology Office of Siemens Healthineers. Driven by the need of interdisciplinary and self-sustaining infrastructures which are accessible for the entire departments, ITT was established in 2005. The global ITT infrastructure includes multiple innovation labs across Germany, China, India, Turkey, the United States, United Arab Emirates, and United Kingdom, addressing projects from 23 Siemens locations. The program success and recognition led to the establishment of ITT locations at prestigious healthcare institutions and universities.

    ITT was founded and is headed globally by Prof. Sultan Haider, who is a Principal Key Expert at Siemens Healthineers (SHS), a title awarded to him by SHS Managing Board in the year 2008 for his outstanding innovation track record which includes the establishment of 32 innovation activity locations and over 500 inventions and patents filed. Furthermore, Prof. Haider has been awarded honorary directorships, professorships and has developed innovation infrastructures and implemented innovation management certification programs for top institutions.

    • 32 ITT activity locations established (ITT Labs/ ITT Certification Programs)
    • 86 ITT certification programs conducted worldwide
    • 2500 + R&D and strategy projects experience
    • Filed more than 1,500 inventions and patents
    • 200 ITT Fellowships offered annually. Engaged with over 2500 researchers, professors and students from over 150 universities in 38 countries
    • 900 + hospital visits conducted for various healthcare requirement engineering projects

    Vision

    Proactively drive innovation to improve human life

    Mission

    Utilizing global self-sustaining innovation infrastructures to accelerate identifying and implementing new business opportunities